Vasopressin for agnosia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Feb 2018: Trial registered, NCT03446456
  2. 17 Sep 2018: Trial started, NCT03446456

The trials

NCT03446456: Vasopressin and Pain Perception in the Brain

State
Under way
Phase
Phase 1 and Phase 2
People
56 planned
Started
17 Sep 2018
Primary completion
31 Dec 2026
Arms
Arginine vasopressin
Results
Posted on the registry
  1. 26 Feb 2018: Trial registered
  2. 17 Sep 2018: Trial started
  3. 16 Dec 2021: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Arginine Vasopressin, Early Vasopressin, Vasostrict.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.